Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers
- PMID: 8472992
- PMCID: PMC1374151
- DOI: 10.1136/gut.34.3.409
Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers
Abstract
Ethane exhalation was measured in 42 control subjects, 52 patients with various non-alcoholic liver diseases, and 89 alcohol abusers who had been admitted to hospital for alcohol withdrawal and assessment of liver disease (six with normal liver tests, 10 with steatosis with or without fibrosis, six with alcoholic hepatitis, 29 with cirrhosis, 34 with both cirrhosis and alcoholic hepatitis, and four with both cirrhosis and a hepatocellular carcinoma). Ethane exhalation was similar in control subjects and in patients with non-alcoholic liver diseases, but was five times higher in alcohol abusers. Ethane exhalation in alcohol abusers was significantly, but very weakly, correlated with the daily ethanol intake before hospital admission, and the histological score for steatosis, but not with the inflammation or alcoholic hepatitis scores. Ethane exhalation was inversely correlated with the duration of abstinence before the test. In nine alcoholic patients, the exhalation of ethane was measured repeatedly, and showed slow improvement during abstinence. Ethane exhalation was significantly but weakly correlated with the Pugh's score in patients with alcoholic cirrhosis. It is concluded that the mean ethane exhalation is increased in alcohol abusers. One of the possible mechanisms may be the presence of oxidizable fat in the liver. The weak correlation with the Pugh's score is consistent with the contribution of many other factors in the progression to severe liver disease.
Similar articles
-
Effect of the hepatocarcinogenic peroxisome proliferator Wy-14,643 in vivo: no increase in ethane exhalation or hepatic conjugated dienes.Toxicol Appl Pharmacol. 1995 Dec;135(2):229-36. doi: 10.1006/taap.1995.1228. Toxicol Appl Pharmacol. 1995. PMID: 8545832
-
Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice.J Hepatol. 1996 Feb;24(2):200-8. doi: 10.1016/s0168-8278(96)80030-4. J Hepatol. 1996. PMID: 8907574
-
Ethane exhalation and vitamin E/ubiquinol status as markers of lipid peroxidation in ferrocene iron-loaded rats.Hepatology. 1995 Apr;21(4):1099-105. Hepatology. 1995. PMID: 7705785
-
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7. Exp Mol Pathol. 2017. PMID: 28077318 Review.
-
[Alcoholic liver disease].Wiad Lek. 2003;56(1-2):61-70. Wiad Lek. 2003. PMID: 12901271 Review. Polish.
Cited by
-
Advances in electronic-nose technologies developed for biomedical applications.Sensors (Basel). 2011;11(1):1105-76. doi: 10.3390/s110101105. Epub 2011 Jan 19. Sensors (Basel). 2011. PMID: 22346620 Free PMC article. Review.
-
Identification of acrolein as a novel diagnostic odor biomarker for 1,2,3-trichloropropane-induced hepatotoxicity in Sprague Dawley rats.Toxicol Res. 2024 Jul 13;40(4):639-651. doi: 10.1007/s43188-024-00253-0. eCollection 2024 Oct. Toxicol Res. 2024. PMID: 39345751
-
Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.World J Gastroenterol. 2007 Aug 28;13(32):4295-305. doi: 10.3748/wjg.v13.i32.4295. World J Gastroenterol. 2007. PMID: 17708600 Free PMC article. Review.
-
Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake.Gut. 1994 Nov;35(11):1637-43. doi: 10.1136/gut.35.11.1637. Gut. 1994. PMID: 7828989 Free PMC article.
-
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.Curr Opin Toxicol. 2019 Feb;13:110-117. doi: 10.1016/j.cotox.2018.10.003. Epub 2018 Oct 15. Curr Opin Toxicol. 2019. PMID: 31263795 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical